Good to see you posting a chart amg, always a good read !I tend...

Good to see you posting a chart amg, always a good read !


I tend to agree that this seems to be a case of anticipated news. Wether to be leaked or wether to be derived from the fact that 3 companies are due reporting, is probably impossible to determine and holders will, most likely, be split in two camps of how to interpret this correctly.

Several points which make me lean towards the case of FA overwhelming the market:

1,
OBJ has been supressed since Oct 2010 after the GSK ann which has brought OBJ onto the radar of many who follow GSK closely.
That effort was magnificant to observe and might have just come to an end.

2,
Macro news from the US and now from Euope support a run onto riskier assets, OBJ is overdue for an appreciation.

3,
UK FMCG has not reported since 2010, we do know that a prototype has been produced and marketing team gave its assessment, likely to be positive.
A launch of the product should occur in 2012, provided all goes well.

4,
JV negotiations between the beauty care FMCG and OBJ should come to a close.
The next announcement regarding this partnership should include financial details, particularly since exclusivity is given.

5,
GSK had now 8 months to test in vivo, enough to put forward milestone contracts with other companies in the past for similar developments.






The buying in fact started last week, the giveaway occured yesterday with the strong buy into 1.9 cents.


I particularly enjoy the measured approach of this buying support, pointing towards larger investors who have been waiting on the sidelines.
If so , they should succeed in avoiding a speeding ticket.
Interesting days ahead.